GeneFerm Biotechnology (1796) Monthly Revenue

Market: TPEx (OTC) · Industry: Food · 金穎生技

GeneFerm Biotechnology (1796) reported revenue of NT$58.5 million for Oct 2026, +0.1% year on year and +21.5% from the previous month. Revenue for Jan–Oct 2026 was NT$550.8 million (-1.3% year on year).

In Oct 2026, it ranked No. 30 by revenue among 34 Food companies.

Monthly revenue chart

Oct 2024 NT$52 million24/10Nov 2024 NT$47.5 millionDec 2024 NT$55.4 millionJan 2025 NT$61 millionFeb 2025 NT$44.8 million25/02Mar 2025 NT$60.6 millionApr 2025 NT$58.9 millionMay 2025 NT$51.5 millionJun 2025 NT$57.5 million25/06Jul 2025 NT$46.2 millionAug 2025 NT$64.3 millionSep 2025 NT$55 millionOct 2025 NT$58.5 million25/10Nov 2025 NT$56.9 millionDec 2025 NT$61.9 millionJan 2026 NT$54.4 millionFeb 2026 NT$46 million26/02Mar 2026 NT$52.8 millionApr 2026 NT$51.4 millionMay 2026 NT$46.9 millionJun 2026 NT$70.6 million26/06Jul 2026 NT$64.6 millionAug 2026 NT$57.3 millionSep 2026 NT$48.2 millionOct 2026 NT$58.5 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$58.5 million+0.1%+21.5%
Sep 2026NT$48.2 million-12.4%-16.0%
Aug 2026NT$57.3 million-10.9%-11.3%
Jul 2026NT$64.6 million+39.8%-8.4%
Jun 2026NT$70.6 million+22.8%+50.5%
May 2026NT$46.9 million-8.9%-8.8%
Apr 2026NT$51.4 million-12.6%-2.5%
Mar 2026NT$52.8 million-12.9%+14.6%
Feb 2026NT$46 million+2.7%-15.4%
Jan 2026NT$54.4 million-10.8%-12.1%
Dec 2025NT$61.9 million+11.6%+8.8%
Nov 2025NT$56.9 million+19.7%-2.7%
Oct 2025NT$58.5 million+12.4%+6.3%
Sep 2025NT$55 million+6.4%-14.5%
Aug 2025NT$64.3 million+56.6%+39.2%
Jul 2025NT$46.2 million+18.2%-19.6%
Jun 2025NT$57.5 million+66.5%+11.7%
May 2025NT$51.5 million+55.3%-12.5%
Apr 2025NT$58.9 million+22.1%-2.8%
Mar 2025NT$60.6 million+76.3%+35.2%
Feb 2025NT$44.8 million+35.6%-26.5%
Jan 2025NT$61 million+19.7%+10.1%
Dec 2024NT$55.4 million-5.8%+16.6%
Nov 2024NT$47.5 million-24.0%-8.6%
Oct 2024NT$52 million-15.4%+0.7%

Jan–Oct 2026 cumulative: NT$550.8 million (-1.3% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Food companies

Compare with peers: GeneFerm Biotechnology vs UNI-PRESIDENT / GeneFerm Biotechnology vs GREATWALL / GeneFerm Biotechnology vs CPE

CompanyRevenueYoY
UNI-PRESIDENT1216NT$57.1 billion+5.3%
GREATWALL1210NT$9.66 billion+14.6%
CPE1215NT$2.66 billion+13.4%
TTET1232NT$2.48 billion+33.4%
SFC1227NT$2.08 billion-3.5%
WEI CHUAN1201NT$1.88 billion+4.4%
NAMCHOW1702NT$1.87 billion+3.1%
LHIHC1229NT$1.1 billion+8.0%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16